Glaucomatous optic neuropathy is a disease we all encounter in our daily practices, with an estimated 64 million people affected.1-3 As one of the leading causes of vision loss worldwide, early detection is vital in establishing a treatment plan to reduce the risk of progression. Damage from glaucoma can be traced back to one essential retinal neuron: the ganglion cell.1-6
The balance of ocular health and convenience has tipped in a troublesome direction. While providing convenience is important, especially today, but balance is necessary. The most recent FTC ruling appears to have tipped that balance in a direction where the ramifications on ocular and systemic health are serious.
Our annual technology issue comes at a time when the tools and techniques of eye care are being rethought—sometimes radically—out of sheer necessity. Even before the pandemic, meeting the needs of an aging population was already an uphill climb. We’ve all seen projections of ever-increasing rates of AMD, diabetic retinopathy, glaucoma and cataracts. But a two-month shutdown of practices and a drastic reduction in capacity due to safety measures has upped the stakes.
You’ve taken the kids for their checkups and scheduled your parents’ doctor visits. You even went along to make sure they understand what was happening.
Nikki Iravani, OD, is always on the lookout for a great marketing tip.
Nine women ODs were honored during the fourth annual Theia Awards of Excellence from Women In Optometry magazine.